Morning! I still hold a core position in that stock you are thinking about selling, and will well into 2020. With that being said I do believe this will definitely be the better of the two to own.
A drug that can stop the reactions of nerve gas agents is exciting stuff and will get world recognition one day if the studies prove efficacy. The company is working with the Israeli and United States governments to possibly get some funding to do this study.
The next one is wrestless leg syndrome which the company thinks will be bigger then the nerve gas drug. Again, both these studies are well known by the public. Well known health issues by the public are easy for people to get, and invest in. Which is why I believe this stock will be a dandy.
News 
Market Data 
Discover 
